IL140581A0 - Bispiperidines as antithrombotic agents - Google Patents
Bispiperidines as antithrombotic agentsInfo
- Publication number
- IL140581A0 IL140581A0 IL14058199A IL14058199A IL140581A0 IL 140581 A0 IL140581 A0 IL 140581A0 IL 14058199 A IL14058199 A IL 14058199A IL 14058199 A IL14058199 A IL 14058199A IL 140581 A0 IL140581 A0 IL 140581A0
- Authority
- IL
- Israel
- Prior art keywords
- antithrombotic agents
- bispiperidines
- therepeutically
- fibrinogen
- iib
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809166A FR2781223B1 (fr) | 1998-07-17 | 1998-07-17 | Bispiperidines et leurs applications therapeutiques |
| PCT/FR1999/001745 WO2000003986A1 (fr) | 1998-07-17 | 1999-07-16 | Bispiperidines comme agents antithrombotiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140581A0 true IL140581A0 (en) | 2002-02-10 |
Family
ID=9528732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14058199A IL140581A0 (en) | 1998-07-17 | 1999-07-16 | Bispiperidines as antithrombotic agents |
| IL140581A IL140581A (en) | 1998-07-17 | 2000-12-26 | Bispiperidines, process for their preparation, pharmaceutical compositions containing them and their use in preparing antithrombotic medicaments |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL140581A IL140581A (en) | 1998-07-17 | 2000-12-26 | Bispiperidines, process for their preparation, pharmaceutical compositions containing them and their use in preparing antithrombotic medicaments |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6333338B1 (de) |
| EP (1) | EP1098878B1 (de) |
| JP (1) | JP2002520393A (de) |
| KR (1) | KR100584032B1 (de) |
| CN (1) | CN1286812C (de) |
| AT (1) | ATE256661T1 (de) |
| AU (1) | AU761655B2 (de) |
| BR (1) | BR9912835A (de) |
| CA (1) | CA2337776A1 (de) |
| DE (1) | DE69913701T2 (de) |
| DK (1) | DK1098878T3 (de) |
| EA (1) | EA003674B1 (de) |
| ES (1) | ES2212576T3 (de) |
| FR (1) | FR2781223B1 (de) |
| HU (1) | HUP0103623A3 (de) |
| IL (2) | IL140581A0 (de) |
| NO (1) | NO318963B1 (de) |
| NZ (1) | NZ509170A (de) |
| PL (1) | PL193804B1 (de) |
| PT (1) | PT1098878E (de) |
| SK (1) | SK152001A3 (de) |
| TR (1) | TR200100159T2 (de) |
| UA (1) | UA65631C2 (de) |
| WO (1) | WO2000003986A1 (de) |
| ZA (1) | ZA200100238B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001047874A1 (en) * | 1999-12-24 | 2001-07-05 | Smithkline Beecham P.L.C. | (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| CA2529486A1 (en) * | 2003-06-18 | 2004-12-23 | Nst Neurosurvival Technologies Ltd. | Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| AU2020300002A1 (en) | 2019-07-01 | 2022-02-24 | Tonix Pharma Limited | Anti-CD154 antibodies and uses thereof |
| US20240059781A1 (en) | 2021-01-06 | 2024-02-22 | Tonix Pharma Limited | Methods of inducing immune tolerance with modified anti-cd154 antibodies |
| WO2025248134A1 (en) | 2024-05-31 | 2025-12-04 | Tonix Pharma Limited | Treatment methods comprising administration of modified cd154 antibodies |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
-
1998
- 1998-07-17 FR FR9809166A patent/FR2781223B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-16 PL PL99345418A patent/PL193804B1/pl not_active IP Right Cessation
- 1999-07-16 UA UA2001021081A patent/UA65631C2/uk unknown
- 1999-07-16 AT AT99929495T patent/ATE256661T1/de not_active IP Right Cessation
- 1999-07-16 BR BR9912835-7A patent/BR9912835A/pt not_active Application Discontinuation
- 1999-07-16 SK SK15-2001A patent/SK152001A3/sk unknown
- 1999-07-16 TR TR2001/00159T patent/TR200100159T2/xx unknown
- 1999-07-16 CN CNB998097772A patent/CN1286812C/zh not_active Expired - Fee Related
- 1999-07-16 EA EA200100150A patent/EA003674B1/ru not_active IP Right Cessation
- 1999-07-16 HU HU0103623A patent/HUP0103623A3/hu unknown
- 1999-07-16 PT PT99929495T patent/PT1098878E/pt unknown
- 1999-07-16 US US09/743,910 patent/US6333338B1/en not_active Expired - Fee Related
- 1999-07-16 WO PCT/FR1999/001745 patent/WO2000003986A1/fr not_active Ceased
- 1999-07-16 EP EP99929495A patent/EP1098878B1/de not_active Expired - Lifetime
- 1999-07-16 ES ES99929495T patent/ES2212576T3/es not_active Expired - Lifetime
- 1999-07-16 DE DE69913701T patent/DE69913701T2/de not_active Expired - Fee Related
- 1999-07-16 JP JP2000560094A patent/JP2002520393A/ja active Pending
- 1999-07-16 NZ NZ509170A patent/NZ509170A/en unknown
- 1999-07-16 CA CA002337776A patent/CA2337776A1/en not_active Abandoned
- 1999-07-16 KR KR1020017000665A patent/KR100584032B1/ko not_active Expired - Fee Related
- 1999-07-16 AU AU46290/99A patent/AU761655B2/en not_active Ceased
- 1999-07-16 DK DK99929495T patent/DK1098878T3/da active
- 1999-07-16 IL IL14058199A patent/IL140581A0/xx active IP Right Grant
-
2000
- 2000-12-26 IL IL140581A patent/IL140581A/en not_active IP Right Cessation
-
2001
- 2001-01-09 ZA ZA200100238A patent/ZA200100238B/en unknown
- 2001-01-15 NO NO20010252A patent/NO318963B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9406857D0 (en) | Improvements in or relating to organic compounds | |
| NO933999L (no) | Fibrinogenreseptorantagonister | |
| ATE266399T1 (de) | Neue substituierte triazolverbindungen | |
| TR199701356A2 (xx) | L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler. | |
| AU7743001A (en) | Cyclopentanoindoles, compositions containing such compounds and methods of treatment | |
| ZA981936B (en) | Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase. | |
| ZA983055B (en) | Fungicidal trifluorophenyl-triazolopyrimidines. | |
| TR200000782T2 (tr) | Resorsinol türevleri. | |
| BG105028A (en) | Bridged indenopyrrolocarbazoles | |
| AU2002220715A1 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
| PT892780E (pt) | Analogos de m-amidino fenilo como inibidores do factor xa | |
| BG103096A (en) | Thrombin inhibitors | |
| EP1027056A4 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
| IN2012DE00109A (de) | ||
| ZA943520B (en) | N-alkylthio polyamine derivatives as radioprotective agents. | |
| BG106019A (en) | INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF | |
| MY133390A (en) | Azabicyclic 5ht1 receptor ligands | |
| PL345418A1 (en) | Bispiperidines as antithrombotic agents | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| PT1282617E (pt) | Derivados de hidantoína com afinidade para os receptores da somatostatina | |
| ES8205126A1 (es) | Un procedimiento para la preparacion de un inhibidor del enzima convertidor de la angiotensina. | |
| AU1261395A (en) | Antibodies which inhibit the binding of thrombin to platelets | |
| EA199900959A1 (ru) | Способы снижения содержания фибриногена | |
| EP1205182A3 (de) | Adenosine als Antithrombosemittel | |
| BG102613A (en) | New substituted imidazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |